Fixed Monthly versus Less Frequent Ranibizumab Dosing and Predictors of Visual Response in Exudative Age-Related Macular Degeneration

Purpose. To examine temporal patterns of visual acuity (VA) response to pooled 0.3 mg/0.5 mg ranibizumab treatment in patients with age-related macular degeneration and identify potential baseline predictors of response. Design. Retrospective analysis. Methods. Results from 1824 ranibizumab-treated...

Full description

Bibliographic Details
Main Authors: Seenu M. Hariprasad, Lawrence S. Morse, Howard Shapiro, Pamela Wong, Lisa Tuomi
Format: Article
Language:English
Published: Hindawi Limited 2012-01-01
Series:Journal of Ophthalmology
Online Access:http://dx.doi.org/10.1155/2012/690641